Juno Therapeutics is a clinical-stage company developing novel cellular immunotherapies based on two distinct and complementary platforms – Chimeric Antigen Receptors (CARs) and T Cell Receptors (TCRs) technologies. Our goal is to revolutionize medicine by re-engaging the body’s immune system to treat cancer.
Webcast - Live Juno Therapeutics ASH 2016 Webcast December 05, 2016 at 11:30 p.m. ET
Juno Therapeutics ASH 2016 Webcast Monday, December 5, 2016 11:30 p.m. ET